References
- Borman AM, Szekely A, Linton CJ, Palmer MD, Brown P, Johnson EM. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol. 2013 Mar;51(3):967–972. https://doi.org/10.1128/JCM.02816-12
- Byadarahally Raju S, Rajappa S. Isolation and identification of Candida from the oral cavity. ISRN Dent. 2011;2011:487921. https://doi.org/10.5402/2011/487921
- CLSI. Performance standards for antifungal susceptibility testing of yeasts. 3rd ed. CLSI supplement M27M44S. Wayne (USA): Clinical and Laboratory Standards Institute; 2022.
- Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods. 2015 Apr;111:50–56. https://doi.org/10.1016/j.mimet.2015.02.004
- Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin Microbiol Infect. 2005 Jun;11(6):486–492. https://doi.org/10.1111/j.1469-0691.2005.01166.x
- Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018 Nov;18(11):e339–e347. https://doi.org/10.1016/S1473-3099(18)30103-8
- EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0. Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; 2020 [cited 2022 Nov 29]. Available from http://www.eucast.org/astoffungi/clinicalbreakpointsforantifungals
- Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, et al. Guideline: vulvovaginal candidosis (AWMF 015/072, level S2k). Mycoses. 2021 Jun;64(6):583–602. https://doi.org/10.1111/myc.13248
- Gharehbolagh SA, Fallah B, Izadi A, Ardestani ZS, Malekifar P, M Borman A, Mahmoudi S. Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: a systematic review and meta-analysis. PLoS One. 2020 Aug;15(8):e0237046. https://doi.org/10.1371/journal.pone.0237046
- Gumral R, Sancak B, Guzel AB, Saraçlı MA, Ilkit M. Lack of Candida africana and Candida dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms. Mycopathologia. 2011 Jul;172(1):73–76. https://doi.org/10.1007/s11046-011-9401-2
- Hazirolan G, Altun HU, Gumral R, Gursoy NC, Otlu B, Sancak B. Prevalence of Candida africana and Candida dubliniensis, in vulvovaginal candidiasis: first Turkish Candida africana isolates from vulvovaginal candidiasis. J Mycol Med. 2017 Sep;27(3):376–381. https://doi.org/10.1016/j.mycmed.2017.04.106
- Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Yazdani Cherati J, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbiol. 2015 Apr;8(4):e15992. https://doi.org/10.5812/jjm.8(4)2015.15992
- Hu Y, Yu A, Chen X, Wang G, Feng X. Molecular characterization of Candida africana in genital specimens in Shanghai, China. Biomed Res Int. 2015;2015:185387. https://doi.org/10.1155/2015/185387
- Jamilian M, Mashadi E, Sarmadi F, Banijamali M, Farhadi E, Ghanatpishe E. [Frequancy of vulvovaginal Candidiasis species in nonpregnant 15–50 years old women in spring 2005 in Arak] (in Persian). J Arak Uni Med Sci 2007;10(2):7–14. http://jams.arakmu.ac.ir/article-1-5-en.html
- Kasprowicz A, Białecka A. [Atlas of vaginal purity degrees. Research procedures, interpretation of results] (in Polish). Wrocław (Poland): MesPharm; 2012. p. 5–45.
- Kolekar K, Tambe S, Aderao R, Nayak C. Chronic vulvovaginitis caused by Candida dubliniensis in an immunologically competent adult female. Int J STD AIDS. 2019 Jan;30(1):90–93. https://doi.org/10.1177/0956462418792113
- McManus BA, Coleman DC, Moran G, Pinjon E, Diogo D, Bougnoux ME, Borecká-Melkusova S, Bujdákova H, Murphy P, d’Enfert C, et al. Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans. J Clin Microbiol. 2008 Feb;46(2):652–664. https://doi.org/10.1128/JCM.01574-07
- Mohammadi F, Hemmat N, Bajalan Z, Javadi A. Analysis of biofilm-related genes and antifungal susceptibility pattern of vaginal Candida albicans and non-Candida albicans species. Biomed Res Int. 2021 May;2021:5598907. https://doi.org/10.1155/2021/5598907
- Moran GP, Coleman DC, Sullivan DJ. Candida albicans versus Candida dubliniensis: why is C. albicans more pathogenic? Int J Microbiol. 2012;2012:205921. https://doi.org/10.1155/2012/205921
- Mucci MJ, Cuestas ML, Landanburu MF, Mujica MT. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina. Rev Iberoam Micol. 2017 Apr–Jun;34(2):72–76. https://doi.org/10.1016/j.riam.2016.09.001
- Naeimi B, Mirhendi H, Khamisipour G, Sadeghzadeh F, Ahmadi B. Candida africana in recurrent vulvovaginal candidiasis (RVVC) patients: frequency and phenotypic and genotypic characteristics. J Med Microbiol. 2018 Nov;67(11):1601–1607. https://doi.org/10.1099/jmm.0.000834
- Neppelenbroek KH, Seó RS, Urban VM, Silva S, Dovigo LN, Jorge JH, Campanha NH. Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Dis. 2014 May;20(4):329–344. https://doi.org/10.1111/odi.12123
- Pakshir K, Bordbar M, Zomorodian K, Nouraei H, Khodadadi H. Evaluation of CAMP-like effect, biofilm formation, and discrimination of Candida africana from vaginal Candida albicans species. J Pathog. 2017;2017:7126258. https://doi.org/10.1155/2017/7126258
- Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004–2008. PLoS One. 2014 Jul;9(7):e101510. https://doi.org/10.1371/journal.pone.0101510
- Romeo O, Criseo G. First molecular method for discriminating between Candida africana, Candida albicans, and Candida dubliniensis by using hwp1 gene. Diagn Microbiol Infect Dis. 2008 Oct; 62(2):230–233. https://doi.org/10.1016/j.diagmicrobio.2008.05.014
- Romeo O, Criseo G. Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana. J Clin Microbiol. 2009 Jan;47(1):212–214. https://doi.org/10.1128/JCM.01540-08
- Scharmann U, Kirchhoff L, Chapot VLS, Dziobaka J, Verhasselt HL, Stauf R, Buer J, Steinmann J, Rath PM. Comparison of four commercially available chromogenic media to identify Candida albicans and other medically relevant Candida species. Mycoses. 2020 Aug; 63(8):823–831. https://doi.org/10.1111/myc.13119
- Shan Y, Fan S, Liu X, Li J. Prevalence of Candida albicans-closely related yeasts, Candida africana and Candida dubliniensis, in vulvovaginal candidiasis. Med Mycol. 2014 Aug;52(6):636–640. https://doi.org/10.1093/mmy/myu003
- Shokoohi G, Javidnia J, Mirhendi H, Rasekh-Jahromi A, Rezaei-Matehkolaei A, Ansari S, Maryami F, Goodarzi S, Romeo O. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: a single-centre experience in Iran. Mycoses. 2021 Jul;64(7):771–779. https://doi.org/10.1111/myc.13280
- Sobel JD, Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opin Pharmacother. 2018 Jun;19(9):971–977. https://doi.org/10.1080/14656566.2018.1476490
- Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 1992 Mar;14(Suppl 1):S148–S153. https://doi.org/10.1093/clinids/14.supplement_1.s148
- Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res. 2004 Jan;4(4–5):369–376. https://doi.org/10.1016/S1567-1356(03)00240-X
- Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology (Reading). 1995 Jul; 141(7): 1507–1521. https://doi.org/10.1099/13500872-141-7-1507
- Sustr V, Foessleitner P, Kiss H, Farr A. Vulvovaginal candidosis: current concepts, challenges and perspectives. J Fungi. 2020 Nov; 6(4):267. https://doi.org/10.3390/jof6040267
- Theill L, Dudiuk C, Morano S, Gamarra S, Nardin ME, Méndez E, Garcia-Effron G. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina. Rev Argent Microbiol. 2016 Jan–Mar;48(1):43–49. https://doi.org/10.1016/j.ram.2015.10.003
- Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses. 2001 Dec;44(11–12):437–445. https://doi.org/10.1046/j.1439-0507.2001.00707.x
- Vidotto V, Mantoan B, Pugliese A, Pontón J, Quindós G, Aoki S, Ito-Kuwa S. Adherence of Candida albicans and Candida dubliniensis to buccal and vaginal cells. Rev Iberoam Micol. 2003 Jun; 20(2):52–54.
- Wójkowska-Mach J, Pomorska-Wesołowska M, Romanik M, Romaniszyn D. Prevalence and antimicrobial susceptibility profiles of microorganisms associated with lower reproductive tract infections in women from Southern Poland – retrospective laboratory-based study. Int J Environ Res Public Health. 2021 Jan;18(1):335. https://doi.org/10.3390/ijerph18010335
- Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul;70(4):1–187. https://doi.org/10.15585/mmwr.rr7004a1
- Yazdanpanah A, Khaithir TM. Issues in identifying germ tube positive yeasts by conventional methods. J Clin Lab Anal. 2014 Jan; 28(1):1–9. https://doi.org/10.1002/jcla.21635
- Zangl I, Pap IJ, Aspöck C, Schüller C. The role of Lactobacillus species in the control of Candida via biotrophic interactions. Microb Cell. 2019 Nov;7(1):1–14. https://doi.org/10.15698/mic2020.01.702